Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07SBP
|
|||
| Drug Name |
AZD4831
|
|||
| Indication | Heart failure [ICD-11: BD10-BD13; ICD-10: I50, I50.9; ICD-9: 428] | Phase 1 | [1] | |
| Company |
AstraZeneca Wilmington, DE
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Myeloperoxidase (MPO) | Target Info | Modulator | [1] |
| KEGG Pathway | Phagosome | |||
| Transcriptional misregulation in cancer | ||||
| Pathway Interaction Database | C-MYB transcription factor network | |||
| IL23-mediated signaling events | ||||
| WikiPathways | Folate Metabolism | |||
| Vitamin B12 Metabolism | ||||
| Selenium Micronutrient Network | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.